Related Experiment Videos
Myocardial energetics in dilated cardiomyopathy
L Thierfelder1, C H Holubarsch, G Hasenfuss
1Universitätsklinik Freiburg, Innere Medizin III, Federal Republic of Germany.
Clinical Cardiology
|September 1, 1990
Summary
Drug interventions in idiopathic dilated cardiomyopathy (IDCM) affect myocardial energetics. Vasodilators save energy, while positive inotropes consume it, influencing overall drug effects in IDCM patients.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Idiopathic dilated cardiomyopathy (IDCM) affects myocardial energetics.
- Understanding drug effects on myocardial oxygen consumption (MVO2) is crucial for IDCM management.
Purpose of the Study:
- To assess hemodynamic and energetic effects of different drug interventions on IDCM.
- To determine the impact of vasodilators and inotropes on myocardial energetics.
Main Methods:
- Measured hemodynamic variables and MVO2 in 37 IDCM patients using heart catheterization.
- Analyzed MVO2 from myocardial blood flow and aortocoronary sinus blood oxygen difference.
- Correlated MVO2 with systolic stress time integral (STI).
Main Results:
- Nitroprusside (vasodilator) reduced STI and MVO2 equally, not altering the MVO2/STI ratio.
- Pimobendan (calcium sensitizer/PDE inhibitor) reduced STI and MVO2 similarly, not altering the ratio.
- Enoximone (PDE inhibitor) significantly reduced STI but minimally reduced MVO2, increasing the MVO2/STI ratio.
- Xamoterol (beta-1 agonist) increased MVO2 without changing STI, also increasing the MVO2/STI ratio.
Conclusions:
- Vasodilation demonstrates energy-saving effects in IDCM.
- Positive inotropism is an energy-consuming process in IDCM.
- The net effect of combined inotropic and vasodilating drugs depends on the balance between these properties.